论文部分内容阅读
目的为了研究血液灌流联合血液透析治疗尿毒症的临床疗效,积累尿毒症临床治疗经验,为以后治疗工作提供参考。方法 100例尿毒症患者,将患者随机分为实验组和对照组,每组50例,对照组患者采用常规血液透析进行治疗,实验组患者采用血液灌流联合血液透析方法进行治疗。结果两组患者的病情都有不同程度的改善,其中,实验组患者中,高血压降为15例,皮肤瘙痒降为9例,与对照组患者相比,血红蛋白和红细胞比容含量都有明显上升。结论血液灌流联合血液透析治疗对清除患者体内的甲状旁腺素、分子物质及有毒物质有积极的作用,相比于传统血液透析治疗尿毒症的方法具有明显的优势,值得临床广泛推广。
Objective To study the clinical efficacy of hemoperfusion combined with hemodialysis in the treatment of uremia and to accumulate experience in clinical treatment of uremia and provide reference for future treatment. Methods 100 cases of uremia patients were randomly divided into experimental group and control group, 50 cases in each group. Patients in control group were treated by routine hemodialysis. Patients in experimental group were treated by hemoperfusion combined with hemodialysis. Results Two groups of patients had different degrees of improvement. Among them, 15 cases of hypertension and 9 cases of pruritus in the experimental group were significantly higher than those in the control group, the hemoglobin and hematocrit contents were significantly higher rise. Conclusion Hemoperfusion and hemodialysis have a positive effect on the removal of parathyroid hormone, molecular substances and toxic substances in patients. Compared with traditional hemodialysis, urethral hemodilution has obvious advantages and should be widely popularized in clinic.